Collins Eva-Maria S, Hessel Ellen V S, Hughes Samantha
Swarthmore College, Biology, 500 College Avenue, Swarthmore, PA 19081, USA; Department of Neuroscience, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Center of Excellence in Environmental Toxicology, University of Pennsylvania, Philadelphia, PA, USA.
Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, Bilthoven, 3721 MA, the Netherlands.
Neurotoxicology. 2024 May;102:48-57. doi: 10.1016/j.neuro.2024.03.005. Epub 2024 Mar 28.
Developmental neurotoxicity (DNT) is not routinely evaluated in chemical risk assessment because current test paradigms for DNT require the use of mammalian models which are ethically controversial, expensive, and resource demanding. Consequently, efforts have focused on revolutionizing DNT testing through affordable novel alternative methods for risk assessment. The goal is to develop a DNT in vitro test battery amenable to high-throughput screening (HTS). Currently, the DNT in vitro test battery consists primarily of human cell-based assays because of their immediate relevance to human health. However, such cell-based assays alone are unable to capture the complexity of a developing nervous system. Whole organismal systems that qualify as 3 R (Replace, Reduce and Refine) models are urgently needed to complement cell-based DNT testing. These models can provide the necessary organismal context and be used to explore the impact of chemicals on brain function by linking molecular and/or cellular changes to behavioural readouts. The nematode Caenorhabditis elegans, the planarian Dugesia japonica, and embryos of the zebrafish Danio rerio are all suited to low-cost HTS and each has unique strengths for DNT testing. Here, we review the strengths and the complementarity of these organisms in a novel, integrative context and highlight how they can augment current cell-based assays for more comprehensive and robust DNT screening of chemicals. Considering the limitations of all in vitro test systems, we discuss how a smart combinatory use of these systems will contribute to a better human relevant risk assessment of chemicals that considers the complexity of the developing brain.
发育神经毒性(DNT)在化学物质风险评估中通常不会进行常规评估,因为目前用于DNT的测试范式需要使用哺乳动物模型,而这些模型在伦理上存在争议、成本高昂且资源需求大。因此,人们致力于通过经济实惠的新型替代方法来革新DNT测试,以进行风险评估。目标是开发一套适用于高通量筛选(HTS)的体外DNT测试组合。目前,体外DNT测试组合主要由基于人类细胞的检测方法组成,因为它们与人类健康直接相关。然而,仅靠这些基于细胞的检测方法无法捕捉发育中神经系统的复杂性。迫切需要符合3R(替代、减少和优化)模型的完整生物体系统来补充基于细胞的DNT测试。这些模型可以提供必要的生物体背景,并通过将分子和/或细胞变化与行为读数联系起来,用于探索化学物质对脑功能的影响。线虫秀丽隐杆线虫、涡虫日本三角涡虫和斑马鱼胚胎都适合低成本的高通量筛选,并且每种生物在DNT测试方面都有独特的优势。在这里,我们在一个新颖的综合背景下回顾了这些生物的优势和互补性,并强调它们如何能够增强当前基于细胞的检测方法,以便对化学物质进行更全面、更可靠的DNT筛选。考虑到所有体外测试系统的局限性,我们讨论了如何巧妙地组合使用这些系统,将有助于对考虑发育中大脑复杂性的化学物质进行更符合人类实际情况的风险评估。